previous compound ID: 738 next compound
InChIKey: GMSNIKWWOQHZGF-UHFFFAOYSA-N
SMILES: CN1C2=C(C(=O)NC1=O)NC=N2

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"J Goepp" "R Robert" "SD Macknight" "E Matthes" "GW Carlile" "DY Thomas" "B Kus" "J Liao" "D Rotin" "JW Hanrahan"

chemical graph of compound 738





CID is 70639
synonyms found at PubChem are:
3-Methylxanthine, 1076-22-8, 3-Methyl-1H-purine-2,6(3H,7H)-dione, 2,6-Dihydroxy-3-methylpurine, Xanthine, 3-methyl-, 3 MX, 3-methyl-7H-purine-2,6-dione, 3-METHYL XANTHINE, 1H-Purine-2,6-dione, 3,7-dihydro-3-methyl-, UNII-WS6X982OEC, 3-methyl-2,3,6,7-tetrahydro-1H-purine-2,6-dione, CCRIS 5817, 3-methyl-7H-xanthine, 3,7-Dihydro-3-methyl-1H-purine-2,6-dione, EINECS 214-058-1, CHEMBL619, NSC 515466, WS6X982OEC, CHEBI:62207, GMSNIKWWOQHZGF-UHFFFAOYSA-N, 3-Methyl-3,9-dihydro-purine-2,6-dione, 3-Methyl-3,9-dihydro-1H-purine-2,6-dione, 3-methyl-1,3-dihydropurine-2,6-dione, 3-methyl-3,7(9)-dihydro-purine-2,6-dione, 3-methyl-xanthine, 3-methyl-9H-xanthine, Spectrum_001898, Theophylline Impurity B, 3-methyl-1H-purine-2,6(3H,9H)-dione, SpecPlus_000737, AC1L2EIS, AC1Q6LGD, 3-methyl-3,7-dihydro-1h-purin-2,6-dion, Spectrum2_000502, Spectrum3_001652, Spectrum4_001571, Spectrum5_001544, 3-Methylxanthine, 98%, N(1)-demethyltheophylline, 2-oxo-3-methylhypoxanthine, AC1Q3ZJ4, ACMC-1BT43, Oprea1_233226, Oprea1_288071, BSPBio_003403, KBioGR_002122, KBioSS_002428, KSC492Q5R, BIDD:GT0266, DivK1c_006833, SCHEMBL237146, SPECTRUM1504182, SPBio_000423, ACMC-2098x5, SCHEMBL8663339, Jsp000680, 3-Methyl-3H-purine-2,6-diol, 3-methyl-9H-purine-2,6-dione, CHEBI:62208, CTK3J2858, KBio1_001777, KBio2_002422, KBio2_004990, KBio2_007558, KBio3_002623, KS-00000DPJ, DTXSID90148107, MolPort-000-511-760, MolPort-001-783-700, 1-METHYLXANTHINE (1-MX), 3-Methylxanthine, 98% 250mg, BCP18161, ZERO/005108, ZINC4685854, ANW-15831, BBL012772, BDBM50001515, CCG-39565, GEO-01981, MFCD00005580, NSC515466, SBB002920, STK776266, WLN: T56 BM DN FNVMVJ F1, AKOS002272340, AKOS004120009, AKOS006221835, ZINC100459831, CS-W020049, DS-1280, LS21223, MCULE-1015315695, NSC-515466, RP22873, 3-methyl-3,7-dihydropurine-2,6-dione, 1H-Purine-2, 3,7-dihydro-3-methyl-, NCGC00095330-01, NCGC00095330-02, NCGC00178088-01, 3-Methyl-3,7-dihydro-purine-2,6-dione, AJ-51923, AN-25217, BR-72940, CJ-12209, HY-50723, KB-67712, SC-14084, AB0034663, DB-040769, LS-162544, ST4105010, TC-171085, 3,9-dihydro-3-methyl-1H-purine-2,6-dione, 4CH-013701, AM20080030, FT-0616197, M2073, X8852, C16357, S-2007, 3-Methyl-3,9-dihydro-1H-purine-2,6-dione #, 3-methyl-3,9-dihydro-2H,6H-purine-2,6-dione, 076M228, A801730, I14-4637, J-505016, W-108741, 1H-Purine-2,6-dione, 3,7-dihydro-3-methyl- (9CI), Z1741977122, 3-Methyl-3,9-dihydro-purine-2,6-dione(3-methyl xanthine), 3-Methyl-3,7-dihydro-1H-purine-2,6-dione (3-Methylxanthine), Theophylline Related Compound B, United States Pharmacopeia (USP) Reference Standard